Pharmexcil sees $1.2 billion export hit from EU ban
India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.
Jul 27, 2015, 18:39 PM IST'Pharma exports may have grown 2.2% to $15.2 bn in FY15'
Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.
May 11, 2015, 18:51 PM IST